1,372
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ɛ-caprolactone) copolymer micelles for the delivery of curcumin

, , , , , & show all
Pages 58-68 | Received 11 Feb 2014, Accepted 03 Mar 2014, Published online: 14 Apr 2014

Figures & data

Scheme 1. Synthesis of LDMP.

Scheme 1. Synthesis of LDMP.

Figure 1. FT-IR spectrum of MPEG (A), LDMP (B) and ɛ-CL (C).

Figure 1. FT-IR spectrum of MPEG (A), LDMP (B) and ɛ-CL (C).

Figure 2. 1H-NMR spectrum of tetra-hydroxy MPEG (A) and LDMP (B).

Figure 2. 1H-NMR spectrum of tetra-hydroxy MPEG (A) and LDMP (B).

Figure 3. GPC of LDMP-2.

Figure 3. GPC of LDMP-2.

Table 1. Characteristics of micelles.

Figure 4. TEM of CUR micelles (38 000×, the scale bar is 100 nm).

Figure 4. TEM of CUR micelles (38 000×, the scale bar is 100 nm).

Figure 5. FT-IR spectrum of CUR, blank micelles and CUR micelles.

Figure 5. FT-IR spectrum of CUR, blank micelles and CUR micelles.

Figure 6. XRD of CUR, blank micelles and CUR micelles.

Figure 6. XRD of CUR, blank micelles and CUR micelles.

Figure 7. (A) Hemolysis test UV spectrum of different concentration of LMP, normal saline (negative control), and distilled water (positive control) and (B) percentage of hemolysis of different concentration of LDMP-2.

Figure 7. (A) Hemolysis test UV spectrum of different concentration of LMP, normal saline (negative control), and distilled water (positive control) and (B) percentage of hemolysis of different concentration of LDMP-2.

Figure 8. In vitro CUR-release profiles from either control solution or micelles in 40% ethanol saline solution at 37 °C [data are presented as mean ± SD (n = 3)].

Figure 8. In vitro CUR-release profiles from either control solution or micelles in 40% ethanol saline solution at 37 °C [data are presented as mean ± SD (n = 3)].

Table 2. Mathematical equations for the models used to describe release characteristics of CUR from micelles.

Figure 9. Anticancer activity of free CUR and CUR micelles on HT-29 and Hela cells in vitro after cultivation for 24 and 48 h [data are presented as mean ± SD (n = 4)].

Figure 9. Anticancer activity of free CUR and CUR micelles on HT-29 and Hela cells in vitro after cultivation for 24 and 48 h [data are presented as mean ± SD (n = 4)].

Figure 10. Drug–time curves after i.v. injection of CUR control solution and CUR micelles [data are presented as mean ± SD (n = 6)].

Figure 10. Drug–time curves after i.v. injection of CUR control solution and CUR micelles [data are presented as mean ± SD (n = 6)].

Table 3. Pharmacokinetic parameters of CUR control solution and CUR micelles (n = 6).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.